Trials / Completed
CompletedNCT00360386
ALBION "Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis"
Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 110 (planned)
- Sponsor
- Sanofi · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
* To compare the Kinetics of inhibition of platelet aggregation (aggregometry) and platelet activation (flow cytometry) with different loading doses of clopidogrel * To evaluate the effect on various parameters of inflammation and necrosis and the safety of these loading doses
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Clopidogrel |
Timeline
- Start date
- 2004-03-01
- Primary completion
- 2005-02-01
- Completion
- 2005-02-01
- First posted
- 2006-08-04
- Last updated
- 2010-08-31
Source: ClinicalTrials.gov record NCT00360386. Inclusion in this directory is not an endorsement.